Denis Mottet's team has published an article on the molecular understanding of spinal muscular atrophy in Nature Communications, and has just been awarded by European funding (JPND) to continue their research.
The aim of this project is to study the behaviour of innate immune cells following pulmonary viral infections in order to develop new targeted therapeutic strategies.
This ambitious project, which brings together four European partners, aims to better understand the processes underlying the mechanisms of cerebral cortex folding.
Two studies carried out by researchers from the GIGA CRC IVI at ULiège could provide new insights into how our brains work.
A doctor in biochemistry and researcher at the GIGA, her research focuses on the development of therapeutic strategies to treat vascular diseases and cancers.
A Doctor of Science and researcher within the GIGA-I3 research group, his research focuses on acute myeloid leukemia (AML).
A doctor of biomedical sciences and researcher at GIGA Stem Cells, his research focuses on identifying and characterizing the mechanisms that support tumor progression and promote tumor resistance.
An international team of researchers and clinicians, led by GIGA (ULiège), has just completed a groundbreaking clinical trial on a cohort of 62 patients from ten institutions.
A new therapeutic strategy based on the results of a consortium co-led by Prof. François Jouret (CHU de Liège - GIGA-Cardiovascular) suggests acclimatizing the kidneys to oxygen deprivation in order to prevent diabetic kidney disease.
Grégory Ehx (GIGA-I3), en collaboration avec plusieurs équipes canadiennes, a créé ce programme informatique, rendu libre d'accès, permettant de découvrir des cibles de choix pour créer des vaccins anti-cancer.
Among the grants awarded by the FRS-FNRS this year, 118 will finance research carried out by ULiège scientists.
Michaëls Herfs has been awarded this prize for his original and daring research project focused on cervical cancer.